Rizwan Romee

Dr. Rizwan Romee, an oncologist at the Dana-Farber Cancer Institute and Harvard Medical School professor, dives into the fascinating world of NK cell manipulation for cancer therapy. He discusses groundbreaking approaches for enhancing anti-tumor functions through genetic engineering. The conversation includes the innovative use of E. coli to deliver immune-activating cytokines directly to tumors. Romee also highlights the safety advantages of NK cell therapies compared to CAR T-cells, showcasing a promising path for future cancer treatments.